Patent 10086087 was granted and assigned to Tris Pharma on October, 2018 by the United States Patent and Trademark Office.
A particulate, modified release barrier coated drug-cation exchange resin complex comprising a core composed of a drug complexed with a pharmaceutically acceptable ion-exchange resin is provided. Methods of making and products containing this coated complex are described.